Cannabis Capital Raises and Investors in the U.S. – October 1st – 15th, 2025
Several interesting transactions closed in the Cannabis sector over the past month. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
PIPE
- Forte Group Holdings Inc, offers lifestyle and wellness beverages and nutraceuticals under the flagship TRACE brand, while expanding white-label production for partners, received CAD 625,000 of development capital.
- Flora Growth Corp, a multi-national cannabis company that produces and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products, received $35 million of development capital.
PE Growth/Expansion
- Freddie’s Joint, a cannabis dispensary that serves both medical and recreational cannabis customers, received development capital from Solyco Capital.
Merger/Acquisition
- Adastra Brands, a holding company that manages future branding and commercialization of cannabis products across regulated markets, acquired by Adastra Holdings for $5,000.
- Cambium Analytica, a cannabis testing laboratory that delivers accurate, efficient, and transparent cannabis testing results with optimal customer service, acquired by NSF International.
Equity Crowdfunding
- Aphios, cannabis-based drugs that treat peripheral nervous system disorders, raised $65,993 of equity crowdfunding via Netcapital.
#castleplacement #capitalraising #privateequity #venturecapital #investment #cannabis
Raheem Suleman
Managing Director
Please contact me if you have any questions or would like to discuss your capital raise:
Email: rsuleman@castleplacement.com
(C) 646-852-8007
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
